Patent · US Active

Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease

US10301297B2 · kind B2 · utility

2Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 2, 2018
Grant dateMay 28, 2019
Priority date—
Expiry dateApr 2, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I, as shown below and defined herein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.